Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | Phase I/II Trial of Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer |
---|---|
Disease/Condition | Breast Cancer |
Description | |
Eligibility Criteria | Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements |
Principal Investigator | Della Makower, MD |
Contact Name | Karen Fehn |
Phone | (718) 405-8446 |
Contact Email | CPDMUtrialinfo@montefiore.org |
Protocol Number | IRB# 2014-4040 |
Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
Status | Enolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Adult, Pediatric, Both | Adult |